Profhilo
Profhilo Body for upper arms: what does the 12-month study show?
A 12-month study followed repeated Profhilo Body treatment for inner upper-arm skin laxity, but its single-arm design and intensive schedule limit what can be promised from a routine course.
Upper-arm concerns need a clear diagnosis
The inner upper arms may develop crepey texture, dryness and reduced firmness with age, sun exposure, weight change and individual skin biology. These skin-quality concerns are different from localised fat, reduced muscle tone or a larger amount of excess skin. An injectable cannot be expected to correct every cause.
Profhilo Body is a separate formulation intended for selected body areas and should not be confused with automatically extending a facial treatment plan to the arms. Assessment should identify whether the main concern is superficial skin laxity and whether the degree of likely change would be worthwhile for that person.
What did the 12-month study involve?
A 2025 single-centre study enrolled 34 women aged 37 to 65 with at least early upper-inner-arm laxity and roughness. Participants received two Profhilo Body sessions one month apart, followed by five further sessions at two-month intervals. Thirty-two participants continued through the later treatment phase, with a final assessment one month after the last injection.
Researchers used a photographic laxity scale and participant questionnaires. The median scale score improved by month three and the change was maintained during the treatment period. At least half of participants reported moderate improvement in firmness, smoothness, brightness, hydration and overall appearance at later assessments.
Why the result does not prove a lasting effect from two sessions
There was no untreated, placebo or alternative-treatment group. The study therefore cannot separate the product effect from repeated injections, natural variation, photography or participants' expectations. It also tested seven sessions across a year, so the findings cannot show that an initial two-session course alone would maintain the same change for 12 months.
The sample was small, involved women within a limited age range and came from one centre. Several authors were employees of the manufacturer. A 2026 systematic review found improvement trends across nine Profhilo and Profhilo Body studies, but the treatment areas, methods and measurements differed, and manufacturer employees also contributed to that review. These limitations make guarantees inappropriate.
What may be realistic—and what is not
For a suitable person, the aim may be a gradual, potentially modest improvement in hydration, texture or early laxity. Profhilo Body is not an arm lift, a treatment for weight loss or a reliable way to remove fat, cellulite, stretch marks or substantial excess skin. A visible response may be limited or absent.
The manufacturer's instructions describe two initial sessions 30 days apart, with possible maintenance every two months, while stating that the plan should be adapted to the degree of ageing. This is product guidance rather than proof that every person needs ongoing treatment. Review should compare the original goal and consistent photographs before more sessions are considered.
Downtime and adverse effects
Bruising was recorded in the 12-month study. The instructions also list possible pain, warmth, itching, burning, redness, bruising, oedema or swelling at injection sites. Raised points and tenderness may be visible on the arms, so recovery time should be allowed before sleeveless events, swimming or significant sun exposure.
The manufacturer advises avoiding ultraviolet exposure for three to five days and using very high sun protection. Contact the clinic promptly about severe or increasing pain, spreading redness or heat, discharge, fever, unusual skin colour, marked swelling or symptoms that worsen rather than settle. Breathing difficulty or features of a serious allergic reaction need urgent medical help.
Suitability and consultation come first
The instructions require treatment on healthy skin and advise against use during pregnancy or breastfeeding, with autoimmune disease, active inflammation or a known allergy to the components. Closely timed laser resurfacing or medium-depth peeling is also contraindicated. Medicines, bleeding or healing problems, previous injectable reactions and other planned procedures need individual review.
Consultation should include examination of both arms, realistic alternatives, the number and timing of sessions, downtime, costs and a complication plan. For more advanced laxity, another approach—or no injectable treatment—may be more appropriate. Evidence of average improvement in a small study cannot predict an individual result.